Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M250,741Revenue $M47,735Net Margin (%)23.2Z-Score5.1
Enterprise Value $M257,947EPS $1.7Operating Margin %34.3F-Score7
P/E(ttm))22.0Cash Flow Per Share $0Pre-tax Margin (%)31.0Higher ROA y-yY
Price/Book11.510-y EBITDA Growth Rate %5.4Quick Ratio1.5Cash flow > EarningsY
Price/Sales5.35-y EBITDA Growth Rate %4.9Current Ratio1.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-2.9ROA % (ttm)17.6Higher Current Ratio y-yY
Dividend Yield %3.0Insider Buy (3m)0ROE % (ttm)56.8Less Shares Outstanding y-yN
Payout Ratio %63.0Shares Outstanding M6,795ROI % (ttm)33.6Gross Margin Increase y-yY

Gurus Latest Trades with RHHBY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

RHHBY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
RHHBY Ken Fisher 2014-09-301,891,4060.030.15+4.3%
Premium Most recent portfolio changes are included for Premium Members only!


RHHBY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RHHBY :

    Quarterly/Annual Reports about RHHBY:

      News about RHHBY:

      Articles On GuruFocus.com
      Is Organovo A Safe Buy? Dec 08 2014 
      The Top 5 European Stocks Held During Q3 Nov 25 2014 
      Tweedy Browne Global Reports its Top Five Picks of Q3 Oct 21 2014 
      Widely Held Guru Stocks Trading In Europe Sep 22 2014 
      Dodge & Cox Second Quarter 2014 Commentary Jul 23 2014 
      Tweedy Browne Global Reports Their Second Quarter Portfolio Jul 18 2014 
      Signature Select Canadian Fund's Top Holdings Jul 02 2014 
      The Tweedy Browne Global Value Fund's Top First Quarter Holdings Apr 22 2014 
      Most Popular International Stocks of Investment Gurus Mar 05 2014 
      John Rogers' Ariel Fund Comments on Roche Feb 28 2014 

      More From Our Partners
      Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog Dec 16 2014 - ZACKS

      More From Other Websites
      1:33 am Roche Hldg launches PCR molecular diagnostic system for point of care environment Dec 16 2014
      Roche launches PCR molecular diagnostic system for point of care environment Dec 16 2014
      Xenon Pharmaceuticals Reports Third Quarter 2014 Financial Results Dec 15 2014
      Xenon Pharmaceuticals Reports Third Quarter 2014 Financial Results Dec 15 2014
      Genentech Submits New Drug Application to FDA for Investigational Cobimetinib Used in Combination... Dec 15 2014
      Merck Reveals Data from Breast Cancer Study on Keytruda Dec 11 2014
      PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties Dec 11 2014
      Roche (RHHBY) Presents Positive Data on Haemophilia Drug Dec 10 2014
      AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) Dec 10 2014
      Merck's Keytruda Might Treat Virulent Breast Cancer Dec 10 2014
      Roche Diagnostics purchases tissue dissection technology from AvanSci Bio Dec 10 2014
      Pharmacyclics Presents Imbruvica Data at the ASH Meeting Dec 09 2014
      Celgene Up on Positive Revlimid Data Presented at ASH Dec 09 2014
      ImmunoGen Reports Encouraging Data on Cancer Drug Dec 08 2014
      AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH Dec 08 2014
      Roche to Acquire California-based Ariosa Diagnostics Dec 05 2014
      Genentech to Present Clinical Data from Six Different Medicines at American Society of Hematology... Dec 05 2014
      Puma Biotechnology Down on Delay in Neratinib NDA Filing Dec 03 2014
      AstraZeneca's (AZN) Iressa Accepted for Review in the U.S. Dec 03 2014
      Puma Biotech Stock Plunges On Drug Filing Delay Dec 03 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      Steve.dunfield@google
      ReplySteve.dunfield@google - 8 months ago
      Adjust for split?
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK